Vincerx Pharma, Inc. VINC
0.02
0.00
0.00%
as of 24 Sep
- Market cap
- $250.0K
- P/E
- 0.0×
Follow VINC
Growth Flags
show if company had growth for consecutive years
| Mar '25 | Dec '24 | Sep '24 | Jun '24 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
1.79 | 1.21 | 2.17 | 3.43 |
+8 more quarters Free account |
Net Debt/EBITDA |
1.36 | 0.59 | 1.32 | 2.31 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 0.77 | 0.81 | 3.22 | |
Capex/Depreciation |
— | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.24) | (3.26) | (2.79) | (3.04) | |
Cash per Share |
1.26 | 2.67 | 4.45 | 8.56 | |
Shareholders Equity per Share |
0.58 | 1.44 | 3.99 | 8.06 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.58 | 1.44 | 3.99 | 8.06 | |
Free Cash Flow |
(4.45) | (6.18) | (6.38) | (5.83) | |
Working Capital |
2.07 | 1.13 | 6.32 | 12.95 | |
Net Current Asset Value |
2.07 | 1.13 | 5.91 | 12.20 | |
| Other line items | |||||
Quick Ratio |
1.72 | 1.16 | 2.07 | 3.27 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.24) | (3.26) | (2.79) | (3.04) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Receivables |
— | 1.04 | 1.06 | 1.20 | |
Average Payables |
2.29 | 2.26 | 2.51 | 2.53 | |
Average Assets |
7.88 | 13.11 | 20.61 | 28.40 | |
Average Common Equity |
0.72 | 6.97 | 12.42 | 19.79 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates